| HOME >> MEDICINE >> TECHNOLOGY |
Table 3: Key events impacting the antihormonal therapies market in the seven major markets, 2009-2019 11
Table 4: Antihormonal therapy sales forecasts in the seven major markets ($m), 2009-2019 16
Table 5: Summary of opportunities and threats that will impact the antihormonals market across the seven major markets, 2009-2019 17
Table 6: Sales and growth of antihormonal therapy drug classes in the US ($m), 2009-2019 21
Table 7: Top 5 branded antihormonals in the US in 2009 and 2019 23
Table 8: Antihormonal therapy sales forecasts in the US ($m), 2009-2019 24
Table 9: Summary of opportunities and threats to impact the antihormonals market in the US, 2009-2019 25
Table 10: Sales and growth of antihormonal therapy drug classes in Japan ($m), 2009-2019 28
Table 11: Top 5 branded antihormonals in Japan in 2009 and 2019 30
Table 12: Antihormonal therapy sales forecasts in Japan ($m), 2009-2019 31
Table 13: Summary of opportunities and threats to impact the antihormonals market in Japan, 2009-2019 32
Table 14: Sales and growth of antihormonal therapy drug classes in the five major EU markets ($m), 2009-2019 36
Table 15: Top 5 branded antihormonals in the five major EU markets in 2009 and 2019 38
Table 16: Antihormonal therapy sales forecasts in the five major EU markets ($m), 2009-2019 39
Table 17: Summary of opportunities and threats to impact the antihormonals market in the five major EU markets, 2009-2019 40
Table 18: Risk-sharing agreements between NICE and selected pharma companies in the UK, 2009-2010 46
Table 19: Sales and growth of antihormonal therapy drug classes in France ($m), 2009-2019 48
Table 20: Top 5 branded antihormonals in France in 2009 and 2019 49
Table 21: Antihormonal therapy sales forecasts in France ($m), 2009-2019 50
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |